'Nightmare Bacteria': Maybe Even Worse Than We Thought?

There are under-appreciated emergence of “nightmare bacteria” (Centers for Disease Control and Prevention’s) that are widely distributed in hospitals and nursing homes around the world and do not respond to a last-ditch small family of antibiotics called carbapenems. That seemed dire enough, but new research suggests the problem, bad as it looks, has been understated.

There’s an ahead-of-print article in Antimicrobial Agents and Chemotherapy whose authors include David Shlaes, a physician-researcher and former pharmaceutical executive, now consultant, and Brad Spellberg, an infectious disease physician on the UCLA medical faculty and author among other books of Rising Plague, about antibiotic resistance. In a commentary examining the Food and Drug Administration’s promised “reboot” of antibiotic development rules, they analyze privately gathered data on resistance in the United States and conclude the incidence of highly resistant bacteria is greater than the CDC has estimated.
Read more:
More on 'Nightmare Bacteria': Maybe Even Worse Than We Thought? 

Source:  Wired Science

Art and Science of Laboratory Medicine

Facebook: www.facebook.com/LaboratoryEQAS

Twitter: LaboratoryEQAS